1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 75 Hits
  • 検索条件 : 絞込み (MeSH = Lung Neoplasms / drug therapy)
生物種 リソース名 タイトル
ヒト・動物細胞 Ba/F3(RCB4476) Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations-An In Vitro Study.
ヒト・動物細胞 B16 , COLO 679(RCB0989) Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy.
ヒト・動物細胞 B16F10(RCB2630) A novel amphiphilic squalene-based compound with open-chain polyethers reduces malignant melanoma metastasis in-vitro and in-vivo.
遺伝子材料 tFucci(CA)2/pCSII-EF (RDB15446) A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib.
ヒト・動物細胞 10T1/2(RCB0247) Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions.
ヒト・動物細胞 Ba/F3(RCB0805) Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.
ヒト・動物細胞 HLC-1(RCB0083) , EBC-1(RCB1965) REG Iα gene expression is linked with the poor prognosis of lung adenocarcinoma and squamous cell carcinoma patients via discrete mechanisms.
ヒト・動物細胞 A549(RCB0098) DAP3 Is Involved in Modulation of Cellular Radiation Response by RIG-I-Like Receptor Agonist in Human Lung Adenocarcinoma Cells.
ヒト・動物細胞 A549 , LC-ARERF-LC-AI(RCB0444) The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
ヒト・動物細胞 PC-9(RCB4455) Suppression of tumor immune microenvironment via microRNA-1 after epidermal growth factor receptor-tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma.
ヒト・動物細胞 Ba/F3 Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib.
ヒト・動物細胞 Ba/F3(RCB4476) Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor.
ヒト・動物細胞 HCT116(RCB2979) , DU145(RCB2143) , LNCap.FGC(RCB2144) , B16F10(RCB2630) Petasin potently inhibits mitochondrial complex I-based metabolism that supports tumor growth and metastasis.
ヒト・動物細胞 A549(RCB0098) In vitro evaluation of the cellular effect of indium tin oxide nanoparticles using the human lung adenocarcinoma A549 cells.
遺伝子材料 CSII-CMV-MCS-IRES2-Bsd (RDB04385) , CS-RfA-EVBsd (RDB06090) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
ヒト・動物細胞 Ba/F3(RCB0805) , WEHI-3(RCB0035) EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs.
ヒト・動物細胞 KP4(RCB1005) Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.
ヒト・動物細胞 PC-14(RCB0446) Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
ヒト・動物細胞 RERF-LC-AI(RCB0444) , RERF-LC-KJ(RCB1313) RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition.
ヒト・動物細胞 Ba/F3 Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer.